These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7859136

  • 1. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
    Hughes WT.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar 01; 8(3):247-52. PubMed ID: 7859136
    [Abstract] [Full Text] [Related]

  • 2. Atovaquone: a review.
    Haile LG, Flaherty JF.
    Ann Pharmacother; 1993 Dec 01; 27(12):1488-94. PubMed ID: 8305784
    [Abstract] [Full Text] [Related]

  • 3. Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.
    Spencer CM, Goa KL.
    Drugs; 1995 Jul 01; 50(1):176-96. PubMed ID: 7588086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C, McAfee S, Sackstein R, Finkelstein D, Fishman J, Spitzer T.
    Bone Marrow Transplant; 1999 Oct 01; 24(8):897-902. PubMed ID: 10516703
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atovaquone: a new antipneumocystis agent.
    Artymowicz RJ, James VE.
    Clin Pharm; 1993 Aug 01; 12(8):563-70. PubMed ID: 8222520
    [Abstract] [Full Text] [Related]

  • 13. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.
    Hughes WT, LaFon SW, Scott JD, Masur H.
    J Infect Dis; 1995 May 01; 171(5):1295-301. PubMed ID: 7751706
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
    Groll AH, Ritter J, Müller FM.
    Klin Padiatr; 2001 Sep 01; 213 Suppl 1():A38-49. PubMed ID: 11577363
    [Abstract] [Full Text] [Related]

  • 16. Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration.
    Cotton D.
    AIDS Clin Care; 1995 Jul 01; 7(7):62. PubMed ID: 11362554
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
    Moorman AC, Von Bargen JC, Palella FJ, Holmberg SD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct 01; 19(2):182-8. PubMed ID: 9768629
    [Abstract] [Full Text] [Related]

  • 19. FDA approves new PCP drug. Food and Drug Administration.
    AIDS Alert; 1995 Aug 01; 10(8):108. PubMed ID: 11362680
    [Abstract] [Full Text] [Related]

  • 20. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD, Bogner JR.
    Internist (Berl); 1995 Dec 01; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.